1. (1) the name of the drug; and
2. (2) the date when the drug was approved by the FDA.

The reported approval history shall include the following information for a manufacturer's drug that was approved by the FDA during the three calendar years prior to the effective date of the reported cost increase for the drug product reported in Section R590-287-5:

KEY: data, data reporting, insurance, pharmacy manufacturer

Date of Last Change: May 11, 2022

Authorizing, and Implemented or Interpreted Law: 31A-2-201; 31A-48-103